Global pharmaceutical companies increased their clinical research spending in Korea by 5.3 percent to 1.09 trillion won ($819 ...

For Professor Chang Dong-gune, an orthopedic surgeon at Yeouido St. Mary's Hospital, treating spinal disease increasingly ...

The number of counties in Korea without an obstetrician-gynecologist could nearly triple from nine in 2025 to 25 by 2035, ...

Samjin Pharmaceutical's Lorazepam Injection, an emergency medicine used to stop prolonged seizures, including potentially ...

Daewon Pharmaceutical said Thursday that padoprazan (DW4421), its investigational treatment for gastroesophageal reflux ...

Korea will expand health insurance coverage for five drugs for rare, hard-to-treat diseases next month, extending Crysvita ...

GC Biopharma said Friday it received approval from the Ministry of Food and Drug Safety (MFDS) for Hunterase ICV (idursulfase ...

Curocell, a Korean cell therapy company, said it is seeking to expand the use of its CAR-T therapy Rimqarto (anbalcabtagene ...

The Supreme Court has overturned a lower court ruling upholding a pediatrician's license suspension for administering a ...

KAIST researchers developed an antibody candidate that restored food intake. They improved body weight and muscle strength in ...

GC Biopharma and Hanmi Pharmaceutical said Friday they have signed an exclusive licensing agreement with BioMarin ...

NEX-I plans to pursue global licensing deals for its immuno-oncology and antibody-drug conjugate (ADC) candidates following ...